Column Capital Advisors’s Medtronic MDT Stock Holding History

Column Capital Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$78	Hold	1	–	–	﹤0.01%	791
2023 Q2	$88	Hold	1	–	–	﹤0.01%	801
2023 Q1	$81	Hold	1	–	–	﹤0.01%	819
2022 Q4	$78	Sell	1 -399	-100%	-$32.3K	﹤0.01%	827
2022 Q3	$32K	Hold	400	–	–	0.01%	330
2022 Q2	$36K	Sell	400 -240	-38%	-$24.3K	0.01%	321
2022 Q1	$71K	Buy	640 +264	+70%	+$27.9K	0.01%	247
2021 Q4	$39K	Hold	376	–	–	0.01%	332
2021 Q3	$47K	Hold	376	–	–	0.01%	278
2021 Q2	$47K	Buy	376 +136	+57%	+$17.1K	0.01%	285
2021 Q1	$28K	Hold	240	–	–	0.01%	343
2020 Q4	$28K	Hold	240	–	–	0.01%	348
2020 Q3	$25K	Sell	240 -538	-69%	-$54K	0.01%	335
2020 Q2	$71K	Buy	778 +132	+20%	+$12.7K	0.02%	197
2020 Q1	$58K	Buy	646 +10	+2%	+$1.06K	0.02%	183
2019 Q4	$72K	Buy	+636	New	+$69.8K	0.04%	184

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Column Capital Advisors's MDT Position: Q3 2023 in Review

Column Capital Advisors held its Medtronic (MDT) position steady in Q3 2023 at 1 share worth $78. The position accounts for ﹤0.01% of the portfolio, ranked #791.

Column Capital Advisors first reported a position in MDT in Q4 2019 and has held it in 16 quarters since. The position peaked at $72K in Q4 2019. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

Column Capital Advisors held 1 share of Medtronic worth $78 as of Q3 2023.
Column Capital Advisors left its Medtronic share count unchanged in Q3 2023.
Medtronic made up ﹤0.01% of Column Capital Advisors's portfolio in Q3 2023, its #791 holding.
Column Capital Advisors first reported a position in Medtronic in Q4 2019 and has held it in 16 quarters since.
Column Capital Advisors's Medtronic position peaked at $72K in Q4 2019.
1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.